1. Home
  2. BRID vs GNLX Comparison

BRID vs GNLX Comparison

Compare BRID & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BRID
  • GNLX
  • Stock Information
  • Founded
  • BRID 1932
  • GNLX 2001
  • Country
  • BRID United States
  • GNLX United States
  • Employees
  • BRID N/A
  • GNLX N/A
  • Industry
  • BRID Specialty Foods
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BRID Consumer Staples
  • GNLX Health Care
  • Exchange
  • BRID Nasdaq
  • GNLX Nasdaq
  • Market Cap
  • BRID 70.3M
  • GNLX 112.8M
  • IPO Year
  • BRID N/A
  • GNLX 2023
  • Fundamental
  • Price
  • BRID N/A
  • GNLX $3.09
  • Analyst Decision
  • BRID
  • GNLX Strong Buy
  • Analyst Count
  • BRID 0
  • GNLX 4
  • Target Price
  • BRID N/A
  • GNLX $17.75
  • AVG Volume (30 Days)
  • BRID 5.5K
  • GNLX 137.5K
  • Earning Date
  • BRID 08-22-2025
  • GNLX 08-13-2025
  • Dividend Yield
  • BRID N/A
  • GNLX N/A
  • EPS Growth
  • BRID N/A
  • GNLX N/A
  • EPS
  • BRID N/A
  • GNLX N/A
  • Revenue
  • BRID $224,673,000.00
  • GNLX N/A
  • Revenue This Year
  • BRID N/A
  • GNLX N/A
  • Revenue Next Year
  • BRID N/A
  • GNLX N/A
  • P/E Ratio
  • BRID N/A
  • GNLX N/A
  • Revenue Growth
  • BRID N/A
  • GNLX N/A
  • 52 Week Low
  • BRID $7.50
  • GNLX $1.60
  • 52 Week High
  • BRID $14.69
  • GNLX $5.89
  • Technical
  • Relative Strength Index (RSI)
  • BRID 50.67
  • GNLX 56.10
  • Support Level
  • BRID $7.78
  • GNLX $2.75
  • Resistance Level
  • BRID $8.74
  • GNLX $3.17
  • Average True Range (ATR)
  • BRID 0.22
  • GNLX 0.24
  • MACD
  • BRID 0.01
  • GNLX -0.00
  • Stochastic Oscillator
  • BRID 34.68
  • GNLX 56.94

About BRID Bridgford Foods Corporation

Bridgford Foods Corp manufactures, markets, and distributes frozen and snack food products in the United States. The business segments are; the processing and distribution of frozen products, and the processing and distribution of snack food products. Its product offerings include meat snacks, breads and rolls, biscuits, and ready-to-eat sandwiches among others. The company offers frozen food products to the foodservice and retail customers through wholesalers, cooperatives, and distributors; and snack food items to supermarkets, and mass merchandise and convenience retail stores through customer-owned distribution centers, as well as a direct store delivery network. A majority of the company's revenue is derived from the snack food products segment.

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

Share on Social Networks: